Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

OBIO

Orchestra BioMed Holdings Inc

May 14 • 01:44PM ET

4.86

Dollar change +0.26
Percentage change 5.65	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM IWO SCHA VTWO IWC SCHB VTWG RYLD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.48	Insider Own	37.91%	Shs Outstand	35.78M	Perf Week	-2.41%
Market Cap	173.94M	Forward P/E	-	EPS next Y	-1.69	Insider Trans	0.00%	Shs Float	22.22M	Perf Month	0.41%
Income	-49.12M	PEG	-	EPS next Q	-0.40	Inst Own	36.55%	Short Float	3.85%	Perf Quarter	-23.94%
Sales	2.76M	P/S	63.02	EPS this Y	-7.06%	Inst Trans	-31.90%	Short Ratio	20.65	Perf Half Y	-7.78%
Book/sh	1.90	P/B	2.56	EPS next Y	-6.82%	ROA	-60.16%	Short Interest	0.86M	Perf Year	-71.41%
Cash/sh	2.45	P/C	1.99	EPS next 5Y	-	ROE	-76.29%	52W Range	4.22 - 20.19	Perf YTD	-46.77%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-71.10%	52W High	-75.93%	Beta	0.23
Dividend TTM	-	Quick Ratio	7.94	Sales past 5Y	-7.29%	Gross Margin	74.11%	52W Low	15.17%	ATR (14)	0.35
Dividend Ex-Date	-	Current Ratio	7.95	EPS Y/Y TTM	-697.79%	Oper. Margin	-1866.16%	RSI (14)	49.45	Volatility	5.44% 6.84%
Employees	56	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-1779.71%	Recom	1.00	Target Price	16.33
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	-358.18%	Payout	-	Rel Volume	0.07	Prev Close	4.60
Sales Surprise	-34.74%	EPS Surprise	4.28%	Sales Q/Q	-	Earnings	May 13 AMC	Avg Volume	41.46K	Price	4.86
SMA20	3.22%	SMA50	-5.38%	SMA200	-24.61%	Trades		Volume	2,047	Change	5.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-19-24	Initiated	Jefferies	Buy	$14
Feb-24-23	Initiated	Piper Sandler	Overweight	$15
Feb-07-23	Initiated	Chardan Capital Markets	Buy	$20

May-13-24 09:53PM	OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:05PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:58PM	Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Apr-30-24 08:30AM	Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents (GlobeNewswire)
08:00AM	Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire)
04:17PM	Loading…
Mar-27-24 04:17PM	Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)
Mar-26-24 08:00AM	Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors (GlobeNewswire) +5.20%
Mar-13-24 08:00AM	Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting (GlobeNewswire)
Mar-07-24 08:00AM	Orchestra BioMed to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.62%
Mar-06-24 08:37AM	Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients (GlobeNewswire)
Feb-26-24 08:00AM	Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years (GlobeNewswire)
Feb-16-24 09:13AM	Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season (Zacks) -8.45%
Jan-08-24 07:30AM	Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients (GlobeNewswire) +9.38%
Nov-13-23 04:21PM	Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +14.61%
Nov-09-23 04:42PM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire)
03:52PM	Loading…
Oct-30-23 03:52PM	Billionaire Marc Lasrys Top 10 Stock Picks (Insider Monkey)
Sep-22-23 11:27AM	Lab Notes: Main Line firm spins off company that will focus on OTC product pipeline (American City Business Journals)
Sep-19-23 02:37PM	Rebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coach (TheStreet.com) +27.61%
07:30AM	Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients (GlobeNewswire)
Sep-06-23 05:00PM	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors (GlobeNewswire)
Aug-10-23 04:34PM	Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.05%
Aug-08-23 08:30AM	Orchestra BioMed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon in Patients with Coronary In-Stent Restenosis (GlobeNewswire)
Jul-27-23 09:47AM	Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% (Simply Wall St.) -14.00%
Jun-28-23 02:16PM	Why Shares of Orchestra BioMed Holdings Jumped Wednesday (Motley Fool) +24.85%
Jun-26-23 08:00AM	Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes (GlobeNewswire) -9.81%
Jun-07-23 08:30AM	Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer (GlobeNewswire) -6.42%
Jun-01-23 08:00AM	Orchestra BioMed to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.93%
May-12-23 09:15AM	Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-11-23 05:39AM	3 Stocks That Already Doubled in 2023 and Could Keep Climbing (Motley Fool) +10.12%
Mar-27-23 06:05AM	Orchestra BioMed Holdings Full Year 2022 Earnings: US$14.60 loss per share (vs US$10.90 loss in FY 2021) (Simply Wall St.)
03:52PM	Loading…
Mar-24-23 03:52PM	Why Shares of Orchestra BioMed Jumped This Week (Motley Fool)
Mar-07-23 08:00AM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire) -6.77%
Feb-24-23 08:00AM	Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT and Virtue® SAB at CRT 2023 (GlobeNewswire)
Feb-07-23 08:00AM	Orchestra BioMed Strengthens Senior Leadership Team (GlobeNewswire)

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROSE ERIC A MD	Director	May 17 '23	Option Exercise	1.08	2,325	2,511	2,325	May 19 06:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OBIO

Orchestra BioMed Holdings Inc

Upgrade your FINVIZ experience